Accès gratuit
Med Sci (Paris)
Volume 20, Numéro 3, Mars 2004
Page(s) 325 - 330
Section M/S revues
Publié en ligne 15 mars 2004
  1. Hsich G, Sena-Esteves M, Breakefield XO. Critical issues in gene therapy for neurologic disease. Hum Gene Ther 2002; 13 : 579–604. [Google Scholar]
  2. Pohl M, Braz J. Gene therapy of pain : emerging strategies and future directions. Eur J Pharmacol 2001; 429 : 39–48. [Google Scholar]
  3. Wu CL, Garry MG, Zollo RA, Yang J. Gene therapy for the management of pain. Anesthesiology 2001; 94 : 1119–32. [Google Scholar]
  4. Lin CR, Yang LC, Lee TH, et al. Electroporation-mediated pain-killer gene therapy for mononeuropathic rats. Gene Ther 2002; 9 : 1247–53. [Google Scholar]
  5. Finegold AA, Mannes AJ, Iadarola MI. A paracrine paradigm for in vivo gene therapy in the central nervous system : treatment of chronic pain. Hum Gene Ther 1999; 10 : 1251–7. [Google Scholar]
  6. Wilson SP, Yeomans DC, Bender MA, et al. Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proc Natl Acad Sci USA 1999; 96 : 3211–6. [Google Scholar]
  7. Goss JR, Mata M, Goins WF, et al. Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Ther 2001; 8 : 551–6. [Google Scholar]
  8. Hao S, Mata M, Goins W, et al. Transgene mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain. Pain 2003; 102 : 135–42. [Google Scholar]
  9. Goss JR, Harley CF, Mata M, et al. Herpes vector-mediated expression of proenkephalin reduces bone cancer pain. Ann Neurol 2002; 52 : 662–5. [Google Scholar]
  10. Antunes Bras JM, Epstein AE, Bourgoin S, et al. Herpes simplex virus 1-mediated transfer of preproenkephalin A in rat dorsal root ganglia. J Neurochem 1998; 70 : 1299–303. [Google Scholar]
  11. Braz J, Beaufour C, Coutaux A, et al. Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons. J Neurosci 2001; 21 : 7881–8. [Google Scholar]
  12. Braz J, Meunier A, Beaufour C, et al. Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons. In : Dostrovsky JO, Carr DB, Kotzenburg M, eds. Proceedings of the 10th World congress on pain. Seattle : IASP Press, 2003 : 960 p. [Google Scholar]
  13. Takeba Y, Suzuki N, Kaneko A, et al. Endorphin and enkephalin ameliorate excessive synovial cell functions in patients with rheumatoid arthritis. J Rheumatol 2001; 28 : 2176–83. [Google Scholar]
  14. Oprée A, Kress M. Involvement of the proinflammatory cytokines tumor necrosis factor-a, IL-1b, and IL-6 but not IL-8 in the development of heat hyperalgesia : effects on heat-evoked calcitonin gene-related peptide release from rat skin. J Neurosci 2001; 20 : 6289–93. [Google Scholar]
  15. Inoue A, Ikoma K, Morioka N, et al. Interleukin-1beta induces substance P release from primary afferent neurons through the cyclooxygenase-2 system. J Neurochem 1999; 73 : 2206–13. [Google Scholar]
  16. Junker U, Böhnlein E. Gene therapy for arthritis 1996-1999. Exp Opin Ther Patents 1999; 9 : 1491–8. [Google Scholar]
  17. Watkins LR, Milligan ED, Maier SF. Glial activation : a driving force for pathological pain. Trends Neurosci 2001; 24 : 450–5. [Google Scholar]
  18. Fernandes JC, Martel-Pelletier J, Pelletier JP. Gene therapy for osteoarthritis. Clin Orthop 2000; 379 (suppl) : S262–72. [Google Scholar]
  19. Wagner R, Janjigian M, Myers RR. Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-a expression. Pain 1998; 74 : 35–42. [Google Scholar]
  20. Cunha FQ, Poole S, Lorenzetti BB, et al. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4. Br J Pharmacol 1999; 126 : 45–50. [Google Scholar]
  21. Yao MZ, Gu JF, Wang JH, et al. Interleukin-2 gene therapy of chronic neuropathic pain. Neuroscience 2002; 112 : 409–16. [Google Scholar]
  22. Milligan ED, O’Connor KA, Hamack SE, et al. A novel gene therapy approach for controlling pathological pain states : intrathecal delivery in rats of viral vectors encoding the anti-inflammatory cytokine, interleukin-10. Proceedings of the 10th World congress on pain. Seattle : IASP Press, 2002; 135 (abstract 392-P26). [Google Scholar]
  23. Lu CY, Chou AK, Wu CH, et al. Gene-gun particle with pro-opiomelanocortin cDNA produces analgesia against formalin-induced pain in rats. Gen Ther 2002; 9 : 1008–14. [Google Scholar]
  24. Eaton MJ, Blits B, Ruitenberg MJ, et al. Amelioration of chronic neuropathic pain after partial nerve injury by adeno-associated viral (AAV) vector-mediated over-expression of BDNF in the rat spinal cord. Gen Ther 2002; 9 : 1387–95. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.